Fingerprint
Dive into the research topics of 'A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically